{"nct_id":"NCT05321147","title":"Safety and Efficacy of Lacutamab in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma That Express KIR3DL2","status":"COMPLETED","status_verified_date":"2024-03","start_date":"2022-03-17","start_date_type":"ACTUAL","primary_completion_date":"2023-11-19","primary_completion_date_type":"ACTUAL","completion_date":"2024-02-08","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["IPHA"]}